Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-04-27 | Mr. Christopher Paul WillcoxExecutive Officer, Deputy President, Head of Wholesale & Chairman of Investment Management | -5,05k | 38,97k | Sale to Issuer | 7,71 | 14,59k | -25,73% |
| 2026-04-24 | Mr. Christopher Paul WillcoxExecutive Officer, Deputy President, Head of Wholesale & Chairman of Investment Management | -1,36M | 11,18M | Derivative Exercise and Sale | 8,21 | 14,59k | - |
| 2026-04-27 | Mr. Christopher Paul WillcoxExecutive Officer, Deputy President, Head of Wholesale & Chairman of Investment Management | 9,90k | 0,00 | Derivative Exercise and Retained Stock | - | 14,59k | 211,27% |
| 2026-04-27 | Mr. Yutaka NakajimaRepresentative Executive Officer, Deputy President & Director | -4,70k | 36,21k | Sale to Issuer | 7,71 | 682,74k | -0,68% |
| 2026-04-24 | Mr. Yutaka NakajimaRepresentative Executive Officer, Deputy President & Director | -193,02k | 1,58M | Derivative Exercise and Sale | 8,21 | 682,74k | - |
| 2026-04-27 | Mr. Yutaka NakajimaRepresentative Executive Officer, Deputy President & Director | 9,90k | 0,00 | Derivative Exercise and Retained Stock | - | 682,74k | 1,47% |
| 2026-04-27 | Mr. Kentaro OkudaPresident, Group CEO, Representative Executive Officer & Director | -26,71k | 205,90k | Sale to Issuer | 7,71 | 529,19k | -4,80% |
| 2026-04-24 | Mr. Kentaro OkudaPresident, Group CEO, Representative Executive Officer & Director | -325,48k | 2,67M | Derivative Exercise and Sale | 8,21 | 529,19k | - |
| 2026-04-27 | Mr. Kentaro OkudaPresident, Group CEO, Representative Executive Officer & Director | 57,80k | 0,00 | Derivative Exercise and Retained Stock | - | 529,19k | 12,26% |
| 2026-04-27 | Yukiko OzakiSenior MD, Chief HR Officer & Chief Health Officer | -1,47k | 11,31k | Sale to Issuer | 7,71 | 20,99k | -6,53% |
| 2026-04-24 | Yukiko OzakiSenior MD, Chief HR Officer & Chief Health Officer | -2,90k | 23,78k | Derivative Exercise and Sale | 8,21 | 20,99k | - |
| 2026-04-27 | Yukiko OzakiSenior MD, Chief HR Officer & Chief Health Officer | 4,90k | 0,00 | Derivative Exercise and Retained Stock | - | 20,99k | 30,46% |
| 2026-04-27 | Mr. Takumi KitamuraExecutive Officer & Chief Transformation Officer | -4,33k | 33,38k | Sale to Issuer | 7,71 | 145,53k | -2,89% |
| 2026-04-24 | Mr. Takumi KitamuraExecutive Officer & Chief Transformation Officer | -85,91k | 705,29k | Derivative Exercise and Sale | 8,21 | 145,53k | - |
| 2026-04-27 | Mr. Takumi KitamuraExecutive Officer & Chief Transformation Officer | 9,10k | 0,00 | Derivative Exercise and Retained Stock | - | 145,53k | 6,67% |
| 2026-04-27 | Mr. Go SugiyamaExecutive Officer, Deputy President & Head of Banking | -12,92k | 99,63k | Sale to Issuer | 7,71 | 53,81k | -19,36% |
| 2026-04-24 | Mr. Go SugiyamaExecutive Officer, Deputy President & Head of Banking | -42,06k | 345,31k | Derivative Exercise and Sale | 8,21 | 53,81k | - |
| 2026-04-27 | Mr. Go SugiyamaExecutive Officer, Deputy President & Head of Banking | 27,80k | 0,00 | Derivative Exercise and Retained Stock | - | 53,81k | 106,87% |
| 2026-04-27 | Naotaka MinamiSenior MD & Chief Strategy Officer | -1,99k | 15,32k | Sale to Issuer | 7,71 | 29,08k | -6,40% |
| 2026-04-24 | Naotaka MinamiSenior MD & Chief Strategy Officer | -503,00 | 4,13k | Derivative Exercise and Sale | 8,21 | 29,08k | - |
| 2026-04-27 | Naotaka MinamiSenior MD & Chief Strategy Officer | 4,00k | 0,00 | Derivative Exercise and Retained Stock | - | 29,08k | 15,95% |
| 2026-04-24 | Mr. Koji NagaiChairman of the Board | -220,64k | 35,27M | Derivative Exercise and Sale | 159,84 | 512,94k | - |
| 2026-04-27 | Mr. Toshiyasu IiyamaChief of Staff, Executive Officer, Head of Well Growing Institute & Deputy President | -49,45k | 381,26k | Sale to Issuer | 7,71 | 301,66k | -14,08% |
| 2026-04-24 | Mr. Toshiyasu IiyamaChief of Staff, Executive Officer, Head of Well Growing Institute & Deputy President | -60,75k | 498,72k | Derivative Exercise and Sale | 8,21 | 301,66k | - |
| 2026-04-27 | Mr. Toshiyasu IiyamaChief of Staff, Executive Officer, Head of Well Growing Institute & Deputy President | 107,30k | 0,00 | Derivative Exercise and Retained Stock | - | 301,66k | 55,21% |
| 2026-04-27 | Mr. Sotaro KatoExecutive Officer & Chief Risk Officer | 42,30k | 0,00 | Derivative Exercise and Retained Stock | - | 62,77k | 206,60% |
| 2026-04-24 | Mr. Sotaro KatoExecutive Officer & Chief Risk Officer | -35,74k | 293,39k | Derivative Exercise and Sale | 8,21 | 62,77k | - |
| 2026-04-27 | Mr. Sotaro KatoExecutive Officer & Chief Risk Officer | -22,48k | 173,34k | Sale to Issuer | 7,71 | 62,77k | -26,37% |
| 2026-04-27 | Akihito TobariExec. VP & Director | 10,50k | 0,00 | Derivative Exercise and Retained Stock | - | 105,14k | 11,09% |
| 2026-04-27 | Akihito TobariExec. VP & Director | -6,60k | 50,90k | Derivative Exercise and Sale | 7,71 | 105,14k | - |
| 2026-04-27 | Hiroyasu KoikeInitié | 5,26k | 0,00 | Derivative Exercise and Retained Stock | - | 113,65k | 4,85% |
| 2026-04-27 | Hiroyasu KoikeInitié | -4,74k | 36,58k | Derivative Exercise and Sale | 7,71 | 113,65k | - |
| 2026-04-27 | Takako MoriSenior MD of General Counsel & Joint CCO | 4,12k | 0,00 | Derivative Exercise and Retained Stock | - | 22,93k | 21,92% |
| 2026-04-27 | Takako MoriSenior MD of General Counsel & Joint CCO | -3,78k | 29,14k | Derivative Exercise and Sale | 7,71 | 22,93k | - |
| 2026-04-27 | Akio HoriSenior Managing Director of Group IT & Transformation | 3,15k | 0,00 | Derivative Exercise and Retained Stock | - | 59,34k | 5,60% |
| 2026-04-27 | Akio HoriSenior Managing Director of Group IT & Transformation | -2,95k | 22,76k | Derivative Exercise and Sale | 7,71 | 59,34k | - |
| 2026-04-27 | Hiroyuki MoriuchiExecutive Officer & CFO | 4,82k | 0,00 | Derivative Exercise and Retained Stock | - | 30,68k | 18,66% |
| 2026-04-27 | Hiroyuki MoriuchiExecutive Officer & CFO | -4,38k | 33,74k | Derivative Exercise and Sale | 7,71 | 30,68k | - |
| 2026-04-27 | Yuko HoriuchiSenior Managing Director of Group Finance | 2,77k | 0,00 | Derivative Exercise and Retained Stock | - | 18,45k | 17,67% |
| 2026-04-27 | Yuko HoriuchiSenior Managing Director of Group Finance | -2,63k | 20,28k | Derivative Exercise and Sale | 7,71 | 18,45k | - |
| 2026-04-27 | Mr. Masahiro GotoHead of Executive Management Headquarters & Senior MD | 39,11k | 0,00 | Derivative Exercise and Retained Stock | - | 243,37k | 19,14% |
| 2026-04-27 | Mr. Masahiro GotoHead of Executive Management Headquarters & Senior MD | -30,69k | 236,65k | Derivative Exercise and Sale | 7,71 | 243,37k | - |
| 2026-03-25 | Mr. Masahiro IshizukaIndependent Outside Director | 238,19 | 1,92k | Achat | 8,05 | 10,24k | 2,38% |
| 2026-03-25 | Mr. Shoji OgawaNon-Executive Director | 238,19 | 1,92k | Achat | 8,05 | 58,42k | 0,41% |
| 2026-03-25 | Yukiko OzakiSenior MD, Chief HR Officer & Chief Health Officer | 7,94 | 63,91 | Achat | 8,05 | 17,55k | 0,05% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
